Quote:

---

An undeniable value at these prices. An amazing opportunity for any one not covered or well-positioned. Purchases at this level will be well-rewarded in the coming years. The price could easily rebound with no news.

It's pretty trivial to value the pipeline significantly above the current price:

Brilacidin Platform $1.00/share
Prurisol $0.75/share
Kevetrin $0.50/share

Total $2.25/share (300% of today's price)

This is just a conservative guestimate at today's value with none of the pending news. Risk/reward seems very low at this point.

---

I put this forth about 10 months ago. The only difference between then and now is that we completed B-OM, have no SAEs on Prurisol, and showed Kevetrin to modulate p53 in humans.

And, of course, $2.25/share is now 450% of today's price rather than 300%.

The value here is incredible. Truly a once in a lifetime opportunity.

Go IPIX!